+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

From
Biologics Market Report 2026 - Product Thumbnail Image

Biologics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Filgrastim Biosimilars Market Report 2026 - Product Thumbnail Image

Filgrastim Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pegfilgrastim Biosimilars Market Report 2026 - Product Thumbnail Image

Pegfilgrastim Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Remicade Biosimilar Market Report 2026 - Product Thumbnail Image

Remicade Biosimilar Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biologics CDMO Market Report 2026 - Product Thumbnail Image

Biologics CDMO Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Retinal Biologics Market Report 2026 - Product Thumbnail Image

Retinal Biologics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-CD20 Monoclonal Antibodies Market Report 2026 - Product Thumbnail Image

Anti-CD20 Monoclonal Antibodies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biologics Outsourcing Market Report 2026 - Product Thumbnail Image

Biologics Outsourcing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Bioengineered Protein Drugs Market Report 2026 - Product Thumbnail Image

Bioengineered Protein Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market Report 2026 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Insulin biosimilars Market Report 2026 - Product Thumbnail Image

Insulin biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Bevacizumab Biosimilars Market Report 2026 - Product Thumbnail Image

Bevacizumab Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biopharmaceutical CMO Market Report 2026 - Product Thumbnail Image

Biopharmaceutical CMO Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biobetters Market Report 2026 - Product Thumbnail Image

Biobetters Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Market Report 2026 - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Biopharma Plastics - Global Strategic Business Report 2026 - Product Thumbnail Image

Biopharma Plastics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 307 Pages
  • Global
From
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more